Latest Quarterly Reporting News

Oliver’s Real Food Limited reported a 70% increase in EBIT for the June 2025 quarter, driven by cost-cutting and operational improvements, despite a nearly 6% decline in revenue due to store closures and external factors.

Centuria Capital No. 2 Fund confirms full compliance with note terms and stable loan positions in its Q4 FY25 report, reassuring investors amid a steady operational quarter.

Lion Energy Limited reported a net cash outflow in Q2 2025 but maintains a solid cash position of AUD 2.13 million alongside a convertible note facility, signaling cautious optimism for its exploration activities.

Gullewa Limited reports significant progress in its mining and property ventures, including a major drilling campaign and lot sales, setting the stage for an updated resource estimate.

Brazilian Rare Earths Limited (BRE) confirms Sulista West as an ultra high-grade rare earth project with exceptional drill results and reports metallurgical breakthroughs at Monte Alto, underpinning its integrated supply chain ambitions.

Vitasora Health Limited reported a remarkable 226% increase in patient programs and secured an $11 million capital raise, positioning the company for accelerated growth and a path to cash flow breakeven in late 2026.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.

PentaNet Ltd reported positive operating cash flow for the June 2025 quarter and strengthened its financial position with a new $2 million equipment finance facility.

E79 Gold Mines Limited reported a solid cash position of AUD 2.11 million at the end of June 2025, balancing ongoing exploration costs with fresh financing inflows. The quarterly cash flow report reveals how the company is managing its funding amid active gold exploration.

Austral Resources Australia Ltd reported solid mining progress and processing resilience in Q2 2025, while moving forward with strategic acquisitions and a recapitalisation plan to strengthen its position in Queensland's copper sector.

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.